Literature DB >> 833953

Renal changes in primary aldosteronism.

D N Danforth, M M Orlando, F C Bartter, N Javadpour.   

Abstract

The clinical presentations and renal biopsy specimens of 18 patients with primary aldosteronism were reviewed to determine the characteristic pathologic features of the kidney in this syndrome. All patients were hypertensive with a mean blood pressure of 192 nm. Hg systolic and 122 mm. Hg diastolic. The average duration of hypertension was 6.88 years. The mean serum potassium was 2.88 mEq. per l. and the mean plasma carbon dioxide was 31.4 mEq. per l. A significant history of urinary tract disease was noted in 8 patients. Laboratory and diagnostic studies evaluating renal structure and function were abnormal in 11 patients. Renal biopsies from all 18 individuals showed evidence of parenchymal damage. Hypertensive and hypokalemic changes were the most significant abnormalities and were considered moderate to severe in 78 and 89 per cent of the patients, respectively. Histologic evidence of pyelonephritis was noted in 2 patients only and no renal specimens contained characteristic changes of metabolic alkalosis. The preoperatively hypertensive and renal evaluations did not reflect the severity of the renal changes noted histologically. The extent of renal injury caused by hypertension and hypokalemia in these patients emphasizes the consequences of primary aldosteronism. Early diagnosis and treatment of this disorder are essential if these consequences are to be avoided.

Entities:  

Mesh:

Year:  1977        PMID: 833953     DOI: 10.1016/s0022-5347(17)58376-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.

Authors:  Il Young Kim; In Seong Park; Min Jeong Kim; Miyeun Han; Harin Rhee; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Sang Heon Song; Hyun Chul Chung
Journal:  Int Urol Nephrol       Date:  2018-05-19       Impact factor: 2.370

2.  Worsening of lipid metabolism after successful treatment of primary aldosteronism.

Authors:  Christian Adolf; Evelyn Asbach; Anna Stephanie Dietz; Katharina Lang; Stefanie Hahner; Marcus Quinkler; Lars Christian Rump; Martin Bidlingmaier; Marcus Treitl; Roland Ladurner; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2016-05-14       Impact factor: 3.633

3.  Reliability Analysis of a Functional Diagnostic Test for Primary Hyperaldosteronism Based on Data Analysis.

Authors:  Yan Wang; Jun Cai
Journal:  Comput Intell Neurosci       Date:  2022-06-27

Review 4.  Treatment of Primary Aldosteronism and Organ Protection.

Authors:  Cristiana Catena; GianLuca Colussi; Leonardo A Sechi
Journal:  Int J Endocrinol       Date:  2015-05-17       Impact factor: 3.257

5.  Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.

Authors:  Che-Hsiung Wu; Ya-Wen Yang; Szu-Chun Hung; Yao-Chou Tsai; Ya-Hui Hu; Yen-Hung Lin; Tzong-Shinn Chu; Kwan-Dun Wu; Vin-Cent Wu
Journal:  Sci Rep       Date:  2015-10-19       Impact factor: 4.379

6.  Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.

Authors:  Do Hee Kim; Hee Jin Kwon; Sang A Ji; Hye Ryoun Jang; Sin-Ho Jung; Jung-Han Kim; Jae Hyeon Kim; Jung Eun Lee; Wooseong Huh; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

7.  Incidence of Acute Kidney Injury after Adrenalectomy in Patients with Primary Aldosteronism.

Authors:  Jee Young Lee; Hyoungnae Kim; Hyung Woo Kim; Geun Woo Ryu; Yooju Nam; Seonyeong Lee; Young Su Joo; Sangmi Lee; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Tae-Hyun Yoo; Hae-Ryong Yun
Journal:  Electrolyte Blood Press       Date:  2019-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.